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During early infection, viruses activate cellular stress-response proteins such as heat-shock proteins (Hsps) to counteract
apoptosis, but later on, they modulate these proteins to stimulate apoptosis for efﬁcient viral dissemination. Hsp70 has been
attributed to modulate viral entry, transcription, nuclear translocation and virion formation. It also exerts its anti-apoptotic
function by binding to apoptosis protease-activating factor 1 (Apaf-1) and disrupting apoptosome formation. Here, we show that
inﬂuenza A virus can regulate the anti-apoptotic function of Hsp70 through viral protein M1 (matrix 1). M1 itself did not induce
apoptosis, but enhanced the effects of apoptotic inducers. M1-small-interfering RNA inhibits virus-induced apoptosis in cells
after either virus infection or overexpression of the M1 protein. M1 binds to Hsp70, which results in reduced interaction between
Hsp70 and Apaf-1. In a cell-free system, the M1 protein mediates procaspase-9 activation induced by cytochrome
c/deoxyadenosine triphosphate. A study involving deletion mutants conﬁrmed the role of the C-terminus substrate-binding
domain (EEVD) of Hsp70 and amino acids 128–165 of M1 for this association. The M1 mutants, which did not
co-immunoprecipitate with Hsp70, failed to induce apoptosis. Overall, the study conﬁrms the proapoptotic function of the M1
protein during inﬂuenza virus infection.
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Apoptosis or programmed cell death is a genetically and
biochemically deﬁned process, which has been implicated in
the pathogenesis of various diseases, including bacterial or
viral infections.
1–3 During infection, cell death is induced as a
consequence of activation of host cellular defense mechan-
ism to limit the virus spread by removing infected cells. In
parallel, virus infection or other physiological stress also
activates stress responses to facilitate cell survival. For
example, activation of anti-apoptotic proteins such as
NF-kB, phosphatidylinositol 3-kinase/RAC serine/threonine
protein kinase and heat-shock proteins (Hsps) has been
observed during early stages of replication to delay apoptosis
until completion of their life cycle.
4–6 Conversely, during later
stagesofinfection,virusesexploittheapoptosismachineryfor
efﬁcient propagation and dissemination by activating signals
that either initiate apoptosis or disable anti-apoptotic
pathways.
Hsps mainly function as cellular chaperones to maintain
protein folding and renaturation.
7 Viruses do not have their
own chaperone proteins, and thus they rely on cellular
chaperones for proper folding of their proteins. There are
numerous examples of positive requirement of Hsp40, Hsp70
or Hsp90 by viruses during their replication.
8–10 In contrast,
induction of Hsps has also been correlated with inhibition of
various RNA viruses, including rotavirus and inﬂuenza
viruses.
11 During physiological stress, other than chaperone
activity, Hsps have now been shown to have varied biological
functions such as inhibition of protein aggregation, increasing
protein disaggregation and modulation of apoptosis by
intervening in major apoptotic interactions.
12–15 However,
these stress-response functions of Hsps may not always
involve their chaperone activity. Many Hsps, especially
Hsp70, have been observed to be involved in apoptosis
regulation.
13–15 For example, under stress, when Hsp70
levels are high, it has been shown to exert its anti-apoptotic
function by binding to apoptosis protease-activating factor 1
(Apaf-1), thereby preventing apoptosome formation and
recruitment of caspase-9.
14,15
Inﬂuenza A virus, an enveloped RNA virus of the family
Orthomyxoviridae, possesses a genome of eight negative-
sense RNAs. Inﬂuenza viruses have been shown to induce
Hsps, of which Hsp90 interacts directly with the polymerase
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16 whereas
Hsp70 has been shown to inhibit inﬂuenza virus replication.
17
The non-structural protein 1 (NS1) protein of the inﬂuenza
virus has also been shown to inhibit cleavage of Hsp70 pre-
mRNAs to form mature mRNAs.
18 In addition, like most
eukaryotic viruses, the inﬂuenza virus induces apoptosis both
in vitro and in vivo.
19,20 To counteract apoptosis during early
infection, virus-encoded NS1 protein has been shown to
modulate anti-apoptotic proteins.
21 However, in a later stage
of infection, translocation of the fragment 2 of polymerase
basic 1 (PB1-F2) protein to the mitochondrial membrane
results in depolarization of membrane potential, release of
cytochrome c (cyt c) and activation of caspase-9-mediated
intrinsic apoptotic pathway.
22,23 Activation of the mitochon-
drial apoptotic pathway by interferon-regulatory factor-3-
mediated activation of Bax has also been reported during
RNA virus infection.
24
The M1 of inﬂuenza A virus is a phosphorylated 252 amino-
acid (aa), major structural protein, which tightly associates
with ribonucleoprotein cores while interacting with the
membrane envelope and the cytoplasmic tails of spike
glycoprotein.
25 The M1 protein has been shown to directly
bind to heat-shock cognate protein 70 (Hsc70).
26 As Hsp70 is
the structural homolog of Hsc70 and has also been shown to
modulate caspase-9 activation,
13–15,27,28 a possible inter-
action of M1 with Hsp70 was hypothesized. Thus, in this
study, we analyzed the possible interaction between M1 and
Hsp70 proteins by co-immunoprecipitation experiments. The
domains responsible for this interaction were identiﬁed in both
Hsp70 and M1 using deletion mutants. The study conﬁrms
that binding of the M1 protein to Hsp70 disrupts the Hsp70–
Apaf-1 complex, resulting in formation of functional apopto-
some and activation of caspase-9. Overall, the results
emphasize the signiﬁcant role of virus-encoded proteins in
modulating cellular proteins for exploiting the cellular defense
machinery to their beneﬁt.
Results
M1 enhances caspase activation mediated by cyt c. A549
human lung epithelial cells were transiently transfected with
either M1-small-interfering RNA (siRNA) (60nmol) or left
untreated for 24h, followed by infection with inﬂuenza APR8
strain (A/Puerto Rico/8/34) at 1 multiplicity of infection (m.o.i.).
As a measure of apoptosis, caspase-9 activity was measured
by cleavage of a synthetic substrate tetrapeptide LEHD
(Leu-Glu-His-Asp) conjugated to 7-amino-4-methyl coumarin
(LEHD-AMC). In M1-siRNA-treated and PR8 virus-infected
cells, caspase-9 enzymatic activity decreased signiﬁcantly
(E18-fold) at 14 hour of post infection (h.p.i.) compared with
only virus-infected cells (Figure 1a). Concomitantly, caspase-3
activation was also reduced eightfold in M1-siRNA-treated
cells (24.6 ﬂuorescence unit) as compared with only virus-
infected cells (Figure 1b). Cleavage of caspases into their
proteolytically active subunits was further conﬁrmed by
immunoblotting in which higher levels of cleavage products
of caspase-9 (p37/p35) and caspase-3 (p20/p17) were
observed in only PR8 virus-infected cells but not in
M1-siRNA- and virus-infected cells (Figure 1c). Effective
downregulation of the M1 gene by M1-siRNA was conﬁrmed
by immunoblot analysis (Figure 1d). Thus, the results suggest
the role of the M1 protein in inﬂuenza A virus-induced
apoptosis. Activation of caspase-9 during inﬂuenza A
replication is important as in the presence of caspase-9
and caspase-3 inhibitors, Z-LEHD-FMK (N-benzyloxycarbonyl-
LEHD-methyl-ﬂuoromethylketone derivative) and Z-DEVD-
FMK (benzyloxycarbonyl-Asp-Glu-Val-Asp-ﬂuoromethylketone),
virus replication was signiﬁcantly reduced in A549 cells
(data not shown).
Although the results suggested the role of the M1 protein
during virus-induced apoptosis, it could not be ascertained
whether the M1 protein alone is an apoptotic factor or whether
it exerts its function in cooperation with other inﬂuenza virus
proteins. Moreover, M1-siRNA may indirectly result in
reduced virus replication, thus affecting caspase-9 activation.
To overcome this, the M1 gene was cloned in pcDNA6
(pcD-M1)andtransientlyexpressedin293Tcells.Asnegative
control,cellsweretransientlytransfectedwithanemptyvector
(pcDNA6). After 48h of transfection, cells were treated with
staurosporine (1mM) for 6h. Activation of caspase-9 was
assessed by both ﬂuorometric assay and immunoblotting as
described earlier. Staurosporine treatment resulted in activa-
tion and cleavage of caspase-9 and caspase-3 in both control
and pcD-M1-transfected cells (Figures 2a and b). However,
there was four-fold higher activation in pcD-M1-expressing
cells as early as 2h after treatment (Figures 2a and b). When
cell extracts were immunoblotted, enhanced cleavage of
caspase-9, caspase-7 and caspase-3 was observed in
M1-expressing cells than in controls (Figure 2c). Similarly,
after staurosporine treatment, cleaved fragment (85kDa) of
proapoptotic protein poly (ADP-ribose) polymerase (PARP)
was observed early (2h) in pcD-M1-transfected cells than in
empty vector controls (6h) (Figure 2c). Collectively, these
results conﬁrmed the proapoptotic role of the M1 protein.
M1 binds to the Hsp70 protein and disrupts Hsp70–Apaf-1
interaction. To analyze a possible interaction between
Hsp70 and M1, whole-cell lysates after PR8 infection were
immunoprecipitated with an anti-Hsp70 polyclonal antibody,
followed by immunoblotting with M1 antibody. As shown in
Figure 3a, the M1 protein immunoprecipitated with
endogenous Hsp70. Furthermore, the co-association was
conﬁrmed by reciprocal immunoprecipitation by M1 antibody,
followed by immunoblotting with Hsp70 antibody (Figure 3a,
lane 3).
Previous studies have shown direct binding of Hsp70 to
Apaf-1, which results in inhibition of its oligomerization and
procaspase-9 recruitment.
14,15 To understand whether M1
interaction with Hsp70 affects the Apaf-1–Hsp70 interaction,
cells were either treated with staurosporine or infected with
thePR8strain(8,14,20and26h)orleftuntreated.Whole-cell
extracts were immunoprecipitated using the anti-Hsp70 anti-
body, followed by immunoblotting with the Apaf-1 antibody. In
untreated and staurosporine-treated cells, Apaf-1 co-immuno-
precipitated with Hsp70, whereas weak or no co-immuno-
precipitation was observed in PR8 virus-infected cells
(Figure 3b). The results conﬁrmed inhibition of the
Hsp70–Apaf-1 interaction during inﬂuenza virus infection. To
assess whether the Hsp70–Apaf-1 dissociation in inﬂuenza A
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Cell Death and Diseasevirus-infected cells was due to the M1 protein, experiments
were conducted in the presence of M1-siRNA. Untransfected
or M1-siRNA-transfected cells were infected with the PR8
strain for 14h, and cell extracts were immunoprecipitated
using Apaf-1 antibody. Immunoblotting with the Hsp70 anti-
body revealed signiﬁcantly higher co-immunoprecipitation of
Figure 1 Involvement of M1 in mitochondria-mediated caspase activation during inﬂuenza A/PR8 infection. (a and b) A549 cells were transfected with control siRNA or
M1 siRNA (60nmol), and 24h later, were infected with 1m.o.i. (multiplicity of infection) of inﬂuenza A/PR8 virus. Caspase-9 and caspase-3 activities were determined by
hydrolysis of the LEHD-AMC and DEVD-AFC substrates, respectively. Results are representative of three independent experiments. Values represent means±S.D. of one
experiment with three measurements taken. (c) Caspase processing was assayed by immunoblot analysis for the indicated times. Zymogens and cleavage products are
indicated. (d) Expression of M1 was assessed by immunoblotting in PR8-infected cells and M1-siRNA-treated PR8-infected cells for the indicated times
Figure2 M1-mediatedearlyactivationofcaspasesinstaurosporineinduced293Tcells.(aandb)293TcellsweretransientlytransfectedwithemptycontrolvectororpcD-
M1 and left untreated for 36h before control and transfected cells were treated with staurosporine (1mM, 6h) for the indicated times. Actual enzymatic activity of caspase-9
and caspase-3 in cell lysates of control 293T cells or M1-expressing 293T cells treated with staurosporine was measured ﬂuorometrically by cleavage of LEHD-AMC and
DEVD-AFC, respectively, for the given times. Results are representative of three independent experiments. Values represent means±S.D. of one experiment with three
measurements taken. (c) Immunoblotting was performed using whole-cell lysates for cleavage of caspase-9, caspase-7, caspase-3 and PARP. b-Actin served as an internal
loading control
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Cell Death and DiseaseHsp70 with Apaf-1 in M1-siRNA-treated cells (Figure 3c),
compared with poor association in the absence of M1-siRNA
(Figure 3c, lane 3), suggesting that the M1–Hsp70 interaction
may result in reduced association of Hsp70 with Apaf-1 during
inﬂuenza virus infection. Furthermore, to conﬁrm whether M1
inhibits the Hsp70–Apaf-1 interaction directly or indirectly as a
part of a multi-protein complex, immunoprecipitation experi-
ments were performed in pcD-M1 or pcDNA-6-transfected
293T cells. After 36h, cells were treated with staurosporine
(1mM) for 6h. Whole-cell lysates were immunoprecipitated
with the anti-Hsp70 antibody and immunoblotted with anti-M1
and anti-Apaf-1 antibodies. In M1-overexpressing cells, co-
immunoprecipitation of Hsp70 and M1 was observed
(Figure 3d, middle panel) conﬁrming previous results
(Figure 3a), whereas in control cells, signiﬁcantly higher
levels of Apaf-1 co-immunoprecipitated with Hsp70 after
staurosporine treatment (Figure 3d). In reciprocal immuno-
precipitation using Apaf-1 antibody, Hsp70 co-immuno-
precipitated with Apaf-1 in both M1-expressing and control
cells (Figure 3e); however, Apaf-1 and Hsp70 interaction
was signiﬁcantly reduced (43.0-fold) in M1-expressing
cells (Figure 3e, lane 2), conﬁrming that the M1 protein can
directly bind to Hsp70, which results in reduction in the
Hsp70–Apaf-1 complex even in the absence of inﬂuenza A
virus infection.
M1 inhibits Hsp70-mediated downregulation of cyt
c-induced caspase-9 activation. To conﬁrm the
mechanism of M1-mediated inhibition of anti-apoptotic
function of Hsp70, cyt c-induced activation of caspases
was analyzed in an in vitro system using cell-free extracts
from Jurkat cells.
29 Jurkat cell extracts were used as these
cells were shown to have low levels of basal Hsp70
expression.
13 Addition of cyt c and deoxyadenosine
triphosphate (dATP) resulted in activation of caspase-9
and caspase-3, as determined by cleavage of LEHD-AMC
and Asp-Glu-Val-Asp (DEVD) conjugated to 7-amino-4-
triﬂuoromethyl coumarin (DEVD-AFC) substrates (Figures
4a and b). When puriﬁed Hsp70 (3.58mM) protein was
added along with cyt c and dATP, signiﬁcant inhibition of
caspase activation was observed (Figures 4a and b).
However, when recombinant M1 protein (10mg/ml) was
added along with puriﬁed Hsp70, cyt c/dATP-induced
caspase activation was restored (Figures 4a and b).
Similarly, cleaved 37-kDa (caspase-9) and 19/17-kDa
(caspase-3) fragments were observed only in cyt c/dATP
and in M1/Hsp70/cyt c/dATP-treated but not in Hsp70/cyt
c/dATP-treated cell extracts as assessed by immunoblotting
(Figure 4c). These results indicate that M1 interaction
suppresses Hsp70-mediated inhibition of the intrinsic
pathway during virus infection.
Figure 3 M1 association disrupts Hsp70 binding with Apaf-1 during PR8 infection and also in the absence of other viral proteins. (a) Endogenous Hsp70 was
immunoprecipitated (IP) from A549 extracts during PR8 infection using an anti-Hsp70 antibody and probed for associated proteins with an anti-M1 antibody (lane 2). In
reciprocal immunoprecipitation using an anti-M1 antibody, Hsp70 co-precipitated with M1 (lane 3). (b) Association between Hsp70 and Apaf-1 was analyzed during PR8
infection from 8–26h.p.i. by immunoprecipitation with an anti-Hsp70 antibody, followedby immunoblotting with an anti-Apaf-1 antibody. In parallel, Hsp70–Apaf-1 association
was assessed in cells treated with staurosporine (1mM). During inﬂuenza infection, association between Hsp70 and Apaf-1 was disrupted, whereas Hsp70
immunoprecipitated with Apaf-1 in staurosporine-induced apoptosis. (c) M1-siRNA (50nmol) was transfected in A549 cells and left untreated for 36h before PR8 infection.
After 14h.p.i., immunoprecipitation with Apaf-1 antibody was performed to conﬁrm whether M1 binding with Hsp70 disrupted Apaf-1 binding with Hsp70. Result shows that
when M1 is downregulated by siRNA, the Apaf-1–Hsp70 association is not affected during PR8 infection. (d) 293T cells were either mock transfected or transfected with the
pcD-M1 construct and left untreated for 36h, followed by staurosporine (1mM, 6h) treatment. Cell lysates were then subjected to immunoprecipitation with anti-Hsp70
antibody and immunoblotted with anti-M1 antibody. In parallel, association between Hsp70 with Apaf-1 has been analyzed by immunoprecipitating Hsp70 and probed for
Apaf-1. Compared with control staurosporine-treated cells, pcD-M1-transfected cells showed reduced association of Apaf-1 with Hsp70. Immunoglobulin G served as loading
control. (e) Further Apaf-1 was immunoprecipitated and probed for Hsp70 to assess its association in pcD-M1 transfected cells
Caspase-9 activation regulated by inﬂuenza virus
UC Halder et al
4
Cell Death and DiseaseModulation of Hsp70 mRNA and protein levels in PR8
virus-infected cells. If Hsp70 inhibits cellular apoptosis
after virus infection, then virus may induce Hsp70 expression
for successful completion of its life cycle. mRNA levels of
Hsp70 in the nucleus and cytoplasm were measured by real-
time PCR at different time points during PR8 virus infection.
A signiﬁcant increase in Hsp70 mRNA in the nucleus (430-
fold at 20h.p.i.) was observed (Figure 5a), whereas a stable
but slight decrease (E1.5-fold) in Hsp70 mRNA in the
cytoplasm was observed (Figure 5a). In parallel, a stable
two-fold increase in the heat-shock factor-1 transcript was
observed during 8–26h.p.i. (Figure 5b). As a measure of
inﬂuenza A virus replication, expression of the M1 gene was
analyzed. Signiﬁcant induction of M1 transcription (20–150-
fold) was observed with increasing time after infection
(Figure 5c).
Increase in Hsp70 protein levels after viral infection of cells
haswidely been observed.
17,30 Unlikea signiﬁcantincreasein
theHsp70transcript inthe nucleus, only 2.5–3.5-foldincrease
in the Hsp70 protein was observed after 8–20h.p.i., followed
by downregulation (Figure 5d), which is consistent with the
previous report.
17,18 At later time points of infection, basal
expression level was observed (data not shown).
M1 binds to the SBD of Hsp70. The C-terminal region of
Hsp70 has a regulatory EEVD motif, which has been shown
to be crucial for its activity. Deletion (Hsp70DEEVD) or
substitution with alanine residues for the four C-terminal
aa (Hsp70AAAA) disrupts its intramolecular regulation
and intermolecular interactions.
31 The pFLAG-CMV6-M1
construct was co-transfected with either pcD-Hsp70 or the
Hsp70 mutants (pcD-Hsp70DEEVD or pcD-Hsp70AAAA) in
293T cells. After immunoprecipitation of whole-cell extracts
using anti-Flag antibody, only native Hsp70 co-precipitated
(Figure 6a, lane 2). Mutants Hsp70AAAA and Hsp70 DEEVD
were unable to bind M1 in the cellular environment
(Figure 6a). For conﬁrming direct interaction of proteins
under cell-free conditions, native Hsp70, Hsp70AAAA and
Hsp70DEEVD proteins were immobilized on nickel beads
and then incubated either with the M1 protein or mock
control. After eluting the bead complexes, immunoblotting
with anti-M1 antibody showed that M1 associated with native
Hsp70 but not with Hsp70AAAA or Hsp70DEEVD proteins in
pull-down experiments (Figure 6b). These results conﬁrmed
that the C-terminal EEVD motif of the substrate-binding
domain (SBD) region of Hsp70 is critical for its interaction
with M1.
C-terminal motif of M1 interacts with Hsp70 leading to
caspase-9 activation. Involvement of the C-terminal region
of Hsp70 in M1 binding was conﬁrmed; thus, to identify the
region of the M1 protein involved in this binding, deletion
mutants of M1 were constructed (Figure 6c) based on a
previous report.
26 293T cells were transiently transfected
Figure 4 M1inhibitsHsp70-mediated retardationof caspaseactivation ina cell-freesystem.(aand b)CytosolicextractspreparedfromJurkatTcells wereincubatedwith
cytochromec(10mM)anddATP(1mM)inthepresenceorabsenceofrecombinanthumanHsp70(3.58mM)andorrecombinantM1(10mg/ml)fortheindicatedtimeperiods.
Cleavage activities of caspase-9 and caspase-3 were determined by ﬂuorometric quantiﬁcation of LEHD-AMC and DEVD-AFC substrate cleavage, respectively. Results are
representativeofthreeindependentexperiments.Valuesrepresentmeans±S.D.ofoneexperimentwiththreemeasurementstaken.(c)Caspasecleavagewasassessedby
immunoblot analysis after exogenous addition of cytochrome c (10mM) and dATP (1mM) in presence or absence of recombinant Hsp70 (3.58mM) and recombinant
M1(10mg/ml)
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Cell Death and DiseaseFigure 5 Regulation of Hsp70 expression during virus expression. (a) RNA was isolated from nuclear and cytoplasmic fractions of PR8-infected A549 cells using TRIzol
reagent. Real-time PCR for the Hsp70 gene was performed using SYBR green reagent. In the nucleus, 25–35-fold increase in Hsp70 mRNA levels was observed at
14–20h.p.i. In the cytoplasm, 1.5–2-fold decrease in the Hsp70 transcript was observed after PR8 infection (8–26h.p.i.). (b) In parallel, the HSF1 transcript showed 1.8–2.2-
fold increase throughout virus infection. (c) A signiﬁcant time-dependent increase was observed in mRNA levels of M1 with 80–140-fold increase at 14–26h.p.i, as assessed
byreal-timePCR.(d)Hsp70proteinlevelsduringPR8infectionweredeterminedbyimmunoblottingforindicatedtimepoints.Signiﬁcantincrease(3–3.5fold)wasobservedat
8–20h.p.i., followed by downregulation at 26h.p.i
Figure 6 The EEVD motif of Hsp70 is responsible for binding to 128–165 aa of M1. (a) pFLAG-CMV6-M1 was co-transfected with pcD-Hsp70, pcD-Hsp70AAAA or pcD-
Hsp70DEEVD in 293T cells to assess the importance of EEVD motif in in vivo binding. Immunoprecipitation was performed with anti-Flag antibody to pull down the Flag-M1
protein.ImmunoblottingshowedthatonlynativeHsp70wasprecipitatedalongwithM1butnotwiththemutants.(b)ImportanceoftheEEVDmotifinM1bindingwasconﬁrmed
by an in vitro binding assay. Puriﬁed His-tagged Hsp70, Hsp70AAAA or Hsp70DEEVD proteins (10mg) were pre-immobilized on Ni
þ2 in HBS buffer overnight at 41C. After
washing, beads were incubated with recombinant M1 protein (5mg), then washed and proteins were immunoblotted with anti-M1 antibody. Only native Hsp70 directly bound
with the M1 protein. (c) Schematic drawing of M1 deletion mutants used in this study. Deleted amino acids are indicated by dotted lines. (d) Immunodetection of Hsp70 after
Flag-M1immunoprecipitationof293Tcellstransfectedwithanemptyvector(control),orwithavectorcontainingeitherwild-typeM1cDNAorthemutantsdescribedinpanelc
(left panel). Expression of wild-type and mutants of M1 protein in 293T cells was conﬁrmed by immunoblotting
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Cell Death and Diseasewith an empty vector or pFLAG-M1 or mutants of
M1 (Figure 6d). Co-immunoprecipitation experiments
demonstrated that deletion mutants D128–165 and D128–
201 did not bind to Hsp70, whereas mutants D101–127,
D101–150 and D166–201 co-associated with Hsp70 as
efﬁciently as did wild-type M1 (Figure 6d). All M1 mutants
that failed to immunoprecipitate Hsp70 also lost their ability to
induce staurosporine-mediated caspase-9 and caspase-3
activation (Table 1). Puriﬁed M1, M1D101–127 and
M1D128–165 proteins were immobilized on nickel beads
and incubated with Hsp70. Results indicated that unlike wild-
type M1 protein and mutant M1D101–127 protein, mutant
M1D128–165 protein did not bind to Hsp70 protein
(Figure 7a). Furthermore, in Hsp70-immunodepleted Jurkat
cell extracts, Apaf-1 co-immunoprecipitated with the Hsp70
protein in the presence of mutant M1D128–165, whereas
wild-type M1 disrupted this binding (Figure 7b). In addition, in
the presence of mutant D128–165 protein, no activation of
caspase-9 was observed in cell-free extracts supplemented
with cyt c/dATP and Hsp70 (Figure 7c). Collectively, these
results conﬁrm the role of the C-terminal region (aa 128–165)
of the M1 protein in Hsp70 binding and induction of
apoptosis.
Discussion
Viruses exploit the existing cellular machinery for regulating
their own gene expression. Viral genes are translated based
on their requirements during different stages of the viral life
cycle. For example, during inﬂuenza virus infection, synthesis
of nucleoprotein and NS1 protein is favored during early
infection, whereas synthesis of HA, NA, PB1-F2 and M1
genes is delayed.
32 NS1 has been shown to prevent
apoptosis and interferon induction during early stages,
21
whereas PB1-F2 disrupts mitochondrial function resulting in
release of cyt c and apoptosis for efﬁcient dissemination of
viral progeny during later stages of infection.
22,23 Concur-
rently, a co-relation between activation of caspase-9 and
expression of M1 was also observed at 14h.p.i. (Figures 1c
and d). The proapoptotic role of M1 was validated, as virus-
induced activation of caspase-9 and caspase-3 was inhibited
in the presence of M1-siRNA, and in cells expressing the M1
protein, apoptotic inducers like staurosporine induced
signiﬁcantly higher apoptosis (Figure 2).
Table 1 Effects of different mutants on caspase-9 and caspase-3 activation
Cleavage activity
LEHD-AMC DEVD-AFC
M1 wild type 92.4 89.2
D101–127 88.7 87.6
D101–150 65.5 70.3
D128–165 33 27.9
D128–201 30.8 26
D166–201 79.5 82
Wild-type and other mutant constructs of M1 were transfected in 293T cells and
left untreated for 36h before being treated with staurosporine (1mMf o r6 h ) .
Synthetic substrates were used to measure the actual cleavage activity of
caspase-9 and caspase-3 in the whole-cell lysate. Results are expressed as
means of three independent experiments
Figure 7 Amino acid 128–165 is responsible for direct binding with Hsp70 to prevent Apaf-1 binding and to aid in caspase-9 processing induced by cytochrome c/ATP.
(a)His-taggedM1orM1D128–165(10mg)wasimmobilizedonNi
þ2overnightinHBSat41C,andthenwashedandincubatedwithrecombinantHsp70(10mg)for4hat41C.
Associated Hsp70 was detected by immunoblotting. Wild-type Hsp70 associated with native M1 but not with M1D128–165. (b) Jurkat cell extracts were Hsp70
immunodepleted, before recombinant Hsp70 and M1 or M1D128–165 proteins were added to it incubated and Apaf-1 was immunoprecipitated. Hsp70 did not associate with
Apaf-1 when native M1 was present, but did associate in the absence of M1 or in the presence of M1D128–165 protein. (c) Co-addition of recombinant M1 enhances
processing of procaspase-9 induced by dATP or ATP and cytochrome c in Jurkat cell extracts in the presence of wild-type Hsp70, whereas in the presence of M1D128–165
protein, caspase-9 activation is inhibited
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Cell Death and DiseaseThe functionalrole of Hsp chaperone proteins invirus entry,
replication, transcription, virion assembly, translational reg-
ulation, transformation and mainly protein folding and
maturation during infection is well documented.
10,33
Increased expression of the Hsp70 gene during viral infection
has also been reported.
30 During this study, we observed a
time-dependent increase (25–40-fold) in Hsp70 mRNA in the
nucleus but not in the cytoplasm (Figure 5a). It can be
postulated that NS1 protein’s ability to inhibit translocation of
pre-mRNAs to the cytoplasm
18 may have resulted in
accumulation of Hsp70 transcripts in the nucleus. Further-
more, only 2.5–3.5-fold upregulation of the Hsp70 protein was
observed at 8–20h.p.i., followed by decrease at later time
points (Figure 5d), which is consistent with the previous
report.
17 In spite of low levels of transcripts in the cytoplasm,
increased but steady levels of the Hsp70 protein in cells could
be due to increased stability of the Hsp70 protein and
transcripts during cellular stress to maintain cellular home-
ostasis.
34,35 However, levelsofthe Hsp70proteinincellsafter
virus infection are also regulated stringently, as virus
production was shown to be inhibited in heat-induced cells.
10
On the basis of previous reports and our results, four
observationswerenoted,namely(1)inﬂuenzaAvirusinduces
stress proteins including Hsp70 in cells after infection
30
(Figures 5a and d), (2) under stress when Hsp70 is
upregulated, it can inhibit apoptosis by binding to Apaf-1,
which results in inhibition of apoptosome formation and
caspase-9 recruitment, although basal levels of Hsp70 are
essential during assembly of functional apoptosome,
13–15
(3) during inﬂuenza A virus infection, the M1 protein
modulates activation of caspase-9 and cyt c-mediated
intrinsic pathway (Figures 1a–c, Supplementary Figure S1)
and(4)theM1proteinbindstoHsc70,ahomologoftheHsp70
protein.
26 Thus, we hypothesized that M1 may bind to Hsp70
to modulate its anti-apoptotic function, thus resulting in
enhanced caspase-9 activation. Co-immunoprecipitation ex-
periments showed that the M1 protein expressed either
through virus infection or that the expression vector binds to
Hsp70 (Figure 3, Supplementary Figure S2). In the presence
of the M1 protein, Hsp70–Apaf-1 interaction was signiﬁcantly
reduced. Consistent with caspase activation results (Figures
1a–c), in the presence of M1-siRNA, Hsp70–Apaf-1 binding
was restored (Figure 3c). In the cell-free system also, puriﬁed
M1 protein restored activation of caspase-9 in the presence of
Hsp70, cyt c and dATP (Figures 4a–c), further conﬁrming that
direct interaction between Hsp70 and M1 is responsible for
inhibition of the anti-apoptotic function of Hsp70. These
results are consistent with previous reports, which propose
that at higher concentrations, Hsp70 is anti-apoptotic either
becauseoftheformationofhighmolecular-weightaggregates
of Hsp70/Apaf-1 or because of the change in conformation of
apoptosome which prevents recruitment of caspase-9.
13–15
On the basis of our results, it can be hypothesized that virus-
encoded protein M1 quenches excess Hsp70, which is
induced in the cells as a consequence of virus infection, so
that Apaf-1-mediated apoptosome could be formed for
initiation of apoptosis. Apoptosis is required by viruses for
their proper dissemination, which is the case for inﬂuenza A
virus also, as in the presence of caspase-9 and caspase-3
inhibitors, virus replication and infection were inhibited (data
not shown), which is consistent with previous reports.
36 Low
levels of Apaf-1–Hsp70 association were still observed during
PR8-induced apoptosis, as physiological levels of Hsp70
have been shown to be essential for Apaf-1- and cyt
c-mediated functional apoptosome formation.
14
Deletion mutants of the Hsp70 gene (Figures 6a and b)
conﬁrmed signiﬁcance of the C-terminus acidic region of
Hsp70 for interaction with M1, which could bind only to full-
length Hsp70 protein, but not to Hsp70AAAA or Hsp70EEVD.
The extreme C-terminal-regulatory EEVD motif of Hsp70,
essentialforitsATPaseactivityandsubstratebindingishighly
conserved within the Hsp70 family.
31
The RNA-binding domain (aa 76–103) of the M1 protein
was not found to be essential, but aa 102–201 was shown to
be necessary for M1-Hsc70 binding.
26 Using this as a
reference, several deletion mutants of M1 were constructed
spanning the aa 101–201 region. In addition, Hsp70-binding
sites on M1 were also predicted using LIMBO software (http://
limbo.vub.ac.be/), an algorithm for identifying chaperone-
binding sites in proteins. This algorithm uses data from
binding of bacterial homolog of Hsp70 (DnaK) to cellulose-
immobilized peptides and also from a sequence-based proﬁle
or a position-speciﬁc scoring matrix.
37 The binding motif for
Hsp70 consists of a heptamer having a hydrophobic core of
4–5 residues enriched particularly in Leucine, Isoleucine,
Valine, Phenylalanine, tyrosine and two ﬂanking basic
residues that complement the overall negatively charged
DnaK surface.
38 Four most probable DnaK-binding motifs
were predicted, and out of which except aa 128–134, other
three are excluded by our deletion mutation experiments. As
shown in Figure 6d, 128–201 and 128–165 mutants of M1
failed to immunoprecipitate Hsp70. Mutants preventing
M1–Hsp70 interaction failed to activate caspase-9
(Figure 7c), further suggesting that this interaction is required
for the apoptotic effect of M1 during infection. Moreover, as
Hsp70 binds to the cellular caspase recruitment domain
(CARD)domainofApaf-1,
15itisexpectedtohaveoneormore
common functional domains between the CARD motif and aa
128–165 region of the M1 protein. The eukaryotic linear motif
(http://elm.eu.org/) program predicted occurrence of two
common domain-binding motifs viz. Forkhead-associated
domain 1-binding motif that spans 137–143 aa and PSD-95,
Dlg, ZO-1/2 domain 3 (PSD-95, Dlg, ZO-1/2 domain 3)-binding
motif spanning 151–154 aa between the two proteins, suggest-
ing both Apaf-1 and M1 as binding partners of Hsp70.
In addition to caspase-9, Hsp70 has been reported to
intervene with other apoptotic signaling cascades, such as
caspase-8, c-Jun N-terminal kinase (JNK/SAPK) and apop-
tosis signal-regulating kinase 1 activation.
39 As caspase-8 is
activated during inﬂuenza A infection, its intervention may
prevent cleavage of BH3-interacting domain death agonist
(Bid) into tBid (truncated BH3-interacting domain death
agonist), thus inhibiting ampliﬁcation of the intrinsic pathway
(Supplementary References). However, in the presence of
caspase-8 inhibitor, PR8 infection still activated caspase-9,
suggesting it to be independent of caspase-8 activation
(Supplementary Figure S3). Thus, even though the results
of this study focused on M1-mediated activation of caspase-9
due to reduction in Hsp70–Apaf-1 interaction and resulting in
activation of apoptosis, suppression of anti-apoptotic activity
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Cell Death and Diseaseof Hsp70 by M1 can be attributed to its overall apoptotic
function. Moreover, in the presence of M1-siRNA, cleavage of
bid and phosphorylation of JNK/SAPK was inhibited (Supple-
mentary Figure S4). Overall, the results assert the signiﬁcant
role of virus-encoded proteins in regulation of diverse host
stress-response pathways during virus infection.
Materials and Methods
Viruses, cells and viral infection. Madin-Darby canine kidney (MDCK),
human alveolar epithelial cells (A549), 293T and Jurkat cells were grown in MEM,
Ham’sF12,DMEMandRPMI 1640media supplementedwith 10%heat-inactivated
fetal bovine serum, 2mM L-glutamine, 2mM sodium pyruvate and 1  PSF
(penicillin, streptomycin and fungizone), respectively, at 371C with 5% CO2. For
infection,cellswerewashedwithphosphate-bufferedsaline(PBS)andinfectedwith
PR8 at the indicated m.o.i. in PBS/BA (PBS containing 0.2% bovine serum albumin
(BSA), 1mM MgCl2, 0.9mM CaCl2, 100Units/ml penicillin and 0.1mg/ml
streptomycin) for 45min at 371C. The inoculum was aspirated and A549 or
MDCK cells were incubated in respective media supplemented with 0.2% BSA and
antibiotics. The amount of infectious virus in cell supernatants was determined by
plaque assay as described previously.
40
Constructionofvectors. Vectorswereconstructedusingtheprimershaving
restriction sites as follows:
Antibodies, reagents and inhibitors. Antibodies against M1 (Sc-69824,
Sc-17589) and cyt c(Sc-13560) were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). b-Actin (551527), Apaf-1 (611365), caspase-8 (551244) and Bax
(610983)-speciﬁc antibodies were obtained from BD Biosciences (San Diego, CA,
USA). Antibodies against caspase-9 (9501, 9502),caspase-7(9491,9491),caspase-3
(9662,9664),PARP(9541,9542),Bid(2002)andFlag(DYKDDDDK,2368)werefrom
Cell Signaling Technology, Inc (Danvers, MA, USA). Hsp70 antibody was obtained
from Upstate (Billerica, MA, USA) (NBPI-49250) and BD Biosciences (554243). All
antibodies were used at 1:1000 dilution, except anti-M1 and anti-b-actin, which were
used at 1:500. Staurosporine (Sigma, St. Louis, MO, USA; S5921) was used at
1mM/ml, whereas Horse-heart cyt c (Sigma, C7752) was used at 10mM/ml. ATP
(NEB, P0756S) or dATP (NEB, N0440S) was used at 1mM/ml. Z-IETD-FMK (BD,
550380) was used at 80mM/ml.
Plasmid and siRNA transfection. 293T, A549 and Jurkat cells were either
transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) or siPORT-
NeoFX (Ambion, Austin, TX, USA) according to the manufacturer’s instructions.
Custom-synthetic siRNA (50-CTCCAGATTTGCCTGAAGA-30) against M1 was
obtained from Dharmacon (Lafayette, CO, USA). Control siRNA was obtained from
Qiagen (Hilden, Germany) (All Star Negative Control, 1027280).
Western blot analysis. Total protein was extracted with Totex buffer (20mM
Hepes at pH 7.9, 0.35M NaCl, 20% glycerol, 1% NP-40, 1mM MgCl2, 0.5mM
EDTA, 0.1mM EGTA, 50mM NaF and 0.3mM NaVO3) containing a mixture of
protease and phosphatase inhibitors (Sigma). Immunoblotting was performed with
speciﬁcantibodiesandvisualizedusingECLwesternblottingdetectionkit(Millipore,
Billerica, MA, USA).
Cell fractionation. Cytosolic extracts free of the nuclei and mitochondria were
prepared. In brief, cells were washed in ice-cold PBS,pH 7.2, and then in hypotonic
extraction buffer (HEB: 50mM PIPES pH 7.4,50mM KCl, 5mM EGTA, 2mM
MgCl2, 1mM dithiothreitol and 0.1mM phenylmethylsulfonyl ﬂuoride (PMSF)) and
centrifuged. The pellet was resuspended in HEB and lysed in a Dounce
homogenizer. This cell lysate was centrifuged for 30min at 16000 g at 41C, and
the clariﬁed supernatant was either tested immediately or stored in aliquots at
 801C. Mitochondrial fractions were prepared by resuspending cells in ice-cold
bufferA(250mMsucrose,20mMHEPES,10mMKCl,1.5mMMgCl2,1mMEDTA,
1mM EGTA, 1mM DTT, 17mg/ml PMSF, 8mg/ml aprotinin, 2mg/ml leupeptin (pH
7.4)) and homogenized in a Potter-Thomas homogenizer. Nuclei were pelleted by a
10-min 750g spin. The supernatant was spun at 10000 g for 25min and the
mitochondrial fraction resuspended in buffer A and centrifuged at 10000 g for
Vector Gene RE site Primer sequence
pcDNA6/v5 (Invitrogen) M1 EcoRI 50-GAATTCTATGAGTCTTCTAACCGAGGTCGAAACGTAC-30
XhoI 50-CTCGAGTCACTTGAACCGTTGCATCTGCACC-30
pFLAG-CMV6 (Sigma-Aldrich) M1 EcoRI 50-GAATTCAGATGAGTCTTCTAACCGCGGTCGAAACGTAC-30
EcoRV 5-GATATCTCACTTGAACCGTTGCATCTGCACC-30
pFLAG-CMV6 (Sigma-Aldrich) M1D101–127 EcoRI 50-GCAGTTAAACTGTATATGGGCCTCATATACAACAGG-30
EcoRV 50-GTATATGAGGCCCATATACAGTTTAACTGCTTTGTCC-30
pFLAG-CMV6 (Sigma-Aldrich) M1D101–150 EcoRI 50-GCAGTTAAACTGTATTGTGAACCGATTGCTGACTCCC-30
EcoRV 50-CAGCAATCTGTTCACAATACAGTTTAACTGCTTTGTCC-30
pFLAG-CMV6 (Sigma-Aldrich) M1D128–165 EcoRI 50-GCACTTGCCAGTTGTGTGACAACAACCAATCCACTAATC-30
EcoRV 50ATTGGTTGTTGTCACACAACTGGCAAGTGCACCAGCCACCTG-30
pFLAG-CMV6 (Sigma-Aldrich) M1D128–201 EcoRI 50-GCACTTGCCAGTTGTGCCATGGAGGTTGCTAGTCAGG-30
EcoRV 50-TAGCAACCTCCATGGCACAACTGGCAAGTGCACCAGCCACTG-30
pFLAG-CMV6 (Sigma-Aldrich) M1D166–201 EcoRI 50-CATAGGCAAATGGTGGCCATGGAGGTTGCTAGTCAGG-30
EcoRV 50-CTAGCAACCTCCATGGCCATTTGCCTATGAGACCG-30
pEGFP-C2 (Clontech) M1 XhoI 50-CTCGAGCATGAGTCTTCTAACCGAGGTCGAAACGTAC-30
EcoRI 50-GAATTCTCACTTGAACCGTTGCATCTGCACC-30
pET32a (Novagen) M1 EcoRI 50-GAATTCATGAGTCTTCTAACCGAGGTCGAAACGTAC-30
XhoI 50-CTCGAGTCACTTGAACCGTTGCATCTGCACC-30
pET32a (Novagen) M1D101–127 EcoRI 50-GCAGTTAAACTGTATATGGGCCTCATATACAACAGG-30
XhoI 50-GTATATGAGGCCCATATACAGTTTAACTGCTTTGTCC-30
pET32a (Novagen) M1D128–165 EcoRI 50-GCACTTGCCAGTTGTGTGACAACAACCAATCCACTAATC-30
XhoI 50ATTGGTTGTTGTCACACAACTGGCAAGTGCACCAGCCACCTG-30
pcDNA3.1 (Invitrogen) HSP70 BamHI 50-GGATCCATGGCCAAAGCCGCGGCGATCGGCATC-30
HindIII 50AAGCTTCTAATCTACCTCCTCAATGGTGGGGCCTGACCCAGACC-30
pcDNA3.1 (Invitrogen) HSP70AAAA BamHI 50-GGATCCATGGCCAAAGCCGCGGCGATCGGCATC-30
HindIII 50AAGCTTCTAGCAGCAGCAGCAAATGGTGGGCCTGACCCAGACC-30
pcDNA3.1 (Invitrogen) HSP70DEEVD BamHI 50-GGATCCATGGCCAAAGCCGCGGCGATCGGCATC-30
HindIII 50-AAGCTTCTAAATGGTGGGGCCTGACCCAGACCCTCC-30
pET32a (Novagen) HSP70 EcoRI 50-GAATTCATGGCCAAAGCCGCGGCGATCGGCATC-30
XhoI 50CTCGAGCTAATCTACCTCCTCAATGGTGGGGCCTGACCCAGACC-30
pET32a (Novagen) HSP70AAAA EcoRI 50-GAATTCATGGCCAAAGCCGCGGCGATCGGCATC-30
XhoI 50CTCGAGCTAGCAGCAGCAGCAAATGGTGGGCCTGACCCAGACC-30
pET32a (Novagen) HSP70DEEVD EcoRI 50-GAATTCATGGCCAAAGCCGCGGCGATCGGCATC-30
XhoI 50-CTCGAGCTAAATGGTGGGGCCTGACCCAGACCCTCC-30
Caspase-9 activation regulated by inﬂuenza virus
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Cell Death and Disease25min. Mitochondrial pellets were resuspended and kept in buffer (41C) containing
7M urea, 2M thiourea, 4% CHAPS, 120mM dithiothreitol (DTT), 2% ampholytes
(pH 3–10) and 40mM Tris-HCl for 30min.
Co-immunoprecipitation. Cells were washed with ice-cold PBS and then
lysed in a solution containing 10mM Tris (pH 8.0), 170mM NaCl, 0.5% NP-40 and
protease inhibitors for 30min on ice. Cell debris were removed by centrifugation,
andthesupernatantswereincubatedwith anti-Flag or M1or Apaf-1andanti-Hsp70
antibodies overnight at 41C and with protein A-Sepharose for a further 4h. Beads
were washed four times with 1ml of wash buffer (200mM Tris at pH 8.0, 100mM
NaCl and 0.5% NP-40). Bound proteins were eluted with SDS sample buffer and
separated on 12% SDS-PAGE gels before immunoblotting with anti-Hsp70 and M1
or Apaf-1 antibody, respectively.
Quantitative real-time PCR. Total RNA was isolated using TRIzol
(Invitrogen) according to the manufacturer’s instructions. Nuclear and cytoplasmic
RNA were isolated from previously fractionated nuclear and cytoplasmic extracts of
cells at 41C using TRIzol. cDNA was prepared from 1–2mg of RNA using the
Superscript III reverse transcriptase (Invitrogen) with random hexamer primers.
Real-timePCR reactions(501C for 2min, 951C for 10min,followedby40 cyclesof
951C for 15s and 601C for 30s and 721C for 10min) were performed in triplicate
using SYBR Green (Applied Biosystems, Foster City, CA, USA). Primer sequences
are available on request.
Protein expression and puriﬁcation. Proteins were expressed in C41
(DE3) strain Escherichia coli cells, grown at 371C to an OD600 of 1.0, and then
induced with 0.5 or 1.0mM isopropylthiogalactoside and incubated further at 4h.
The pelleted cells were lysed in buffer A (8M urea, 0.1M NaH2PO4, 0.01M Tris-Cl,
pH 8.0) and centrifuged. The resin was washed with buffer A, and the lysed
supernatant was passed through Ni-NTA spin column (Qiagen). The Ni-NTA spin
column was washed with buffer B (8M urea, 0.1M NaH2PO4, 0.01M Tris-Cl, pH
6.3) and ﬁnally the bound protein was eluted with elution buffer (8M urea, 0.1M
NaH2PO4, 0.01M Tris-Cl, pH 4.5).The elutedprotein was then refoldedto its native
conformation by dialysis for in vitro binding assays. Dialysis buffer contained urea
(8, 6, 4, 2, 1 and 0M), 5mM reduced glutathione, 0.5mM oxidized glutathione,
50mM glycine; pH 9.0, 5mM EDTA, 10% glycerol, 10% glucose, 10% sucrose,
250mM NaCl, 2mM MgCl2, 50mM HEPES-KOH (pH 7.5–7.9), 0.5mM PMSF,
2mg/mlaprotinin and 5mg/mlleupeptin.Proteinswere storedin aliquots at  801C.
Whenever necessary, puriﬁed proteins were subjected to enterokinase cleavage
(EK:substrateratio¼1:42at371Cin50mMTris,pH7.6;reactionwasstoppedby
adding 1mM PMSF and heating at 951C for 10min and then passed through the
Ni-NTA column) to remove His tag.
Preparation of cell-free extracts and in vitro caspase activa-
tion. Jurkat cells were collected by centrifugation and washed twice in ice-cold
PBS. The cell pellet was resuspended in an equal volume of HEB, incubated on ice
for 15min and lysed by 10-s vigorous vortexing after addition of 5% NP-40. Lysates
werethencentrifugedfor5minat 15000 g,andthecytoplasmicsupernatantwas
stored at  701C. Endogenous caspase-9 was activated by adding 1mM dATP/
ATP (NEB) and 10mM horse-heart cyt c (Sigma) to cytosolic extracts (300mg
protein equivalent) and incubating at 371C for respective times. Reactions were
stopped by adding 5  SDS loading buffer and boiling for 5min. Aliquots (50mg)
were also removed for assessment of caspase processing by immunoblot analysis.
Assay for caspase-9 and caspase-3 activation. Cell lysates from
controlcellsand M1-siRNA-treated cellsinfectedwith PR8,pcD-M1-transfectedcell
or extracts of in vitro caspase activation assay, were prepared as described
previously. Actual caspase-9 and caspase-3 cleavage activity was measured using
ApoAlert caspase ﬂuorescent assay kit according to the manufacturer’s instructions
(Clontech,MountainView,CA,USA)thatusessyntheticsubstratesLEHD-AMCand
DEVD-AFC, respectively.
In vitro association of recombinant M1 with Hsp70. Recombinant
native M1 and the M1 mutants (B5mg) were previously immobilized on Ni
2þ by
overnight incubation in HEPES-buffered saline (HBS) at 41C. After extensive
washing in PBS/0.3% Tween to remove unbound protein, M1 proteins were
incubated with Hsp70 (10mg) or Hsp70AAAA (10mg) for 4h at 41C in HBS. Beads
were washed extensively with HBS to remove non-speciﬁcally bound proteins.
Remaining proteins were separated by 4  sample buffer and then analyzed by
SDS-PAGE and immunoblotted for Hsp70. Similarly, in reciprocal experiments,
recombinant Hsp70 or Hsp70AAAA or Hsp70EEVD (B5mg) were pre-immobilized
on Ni
2þ, followed by binding and immunoblotting of M1 (10mg) protein.
In vitro procaspase-9 activation in the presence of recombinant
Hsp70, M1 and mutants. Cyt c (10mg) and dATP/ATP (1mM) were
incubated in the presence or absence of Hsp70 (5mg) or Hsp70AAAA (5mg) or
Hsp70 (5mg) and M1 (10mg) or Hsp70 (5mg) and M1D128–165(10mg) in cytosolic
Jurkatcellextracts(50mgproteinequivalent)at371C.Hsp70andM1proteinswere
pre-incubatedfor 30min at51CbeforedATP/ATPandcytcaddition.Procaspase-9
cleavage was then assessed by immunoblotting as described previously.
Statistical analysis. Data are expressed as mean±S.D. of at least three
independent experiments (nZ3). In all tests, P 0.05 was considered statistically
signiﬁcant.
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